These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2620583)

  • 1. [Prediction of the malignant tendency of hydatidiform mole by determination of DNA content].
    Zhuang GX; Su YK
    Zhonghua Fu Chan Ke Za Zhi; 1989 Sep; 24(5):285-7, 317. PubMed ID: 2620583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of cellular DNA and RNA contents of hydatidiform mole. Two significant parameters indicating malignant nature and prognosis.
    Yin GP; Su YK
    Chin Med J (Engl); 1993 Feb; 106(2):136-40. PubMed ID: 8389273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative analysis of the cellular DNA and RNA contents of hydatidiform mole and its clinical significance].
    Yin GP; Su YK; Zhuang GX
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):538-41, 574. PubMed ID: 7835131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy.
    Fukunaga M
    Gynecol Oncol; 2001 Apr; 81(1):67-70. PubMed ID: 11277652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of nuclear DNA of trophoblastic cells analysis of nuclear DNA distribution and clinical outcome of hydatidiform mole.
    Kashimura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):699-705. PubMed ID: 6864028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review.
    Fukunaga M; Endo Y; Ushigome S
    Cytometry; 1995 Jun; 22(2):135-8. PubMed ID: 7587744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric determination of DNA content in malignant and benign bone tumours.
    Heliö H; Karaharju E; Nordling S
    Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of flow cytometry in diagnosis of hydatidiform moles.
    Fukunaga M; Ushigome S; Fukunaga M; Sugishita M
    Mod Pathol; 1993 May; 6(3):353-9. PubMed ID: 8346184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy of hydatidiform moles and nonmolar conceptuses: a study using flow and tissue section image cytometry.
    Berezowsky J; Zbieranowski I; Demers J; Murray D
    Mod Pathol; 1995 Sep; 8(7):775-81. PubMed ID: 8539237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus.
    Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
    Obstet Gynecol; 1994 Jan; 83(1):35-42. PubMed ID: 8272304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content as a prognostic index in gestational trophoblastic neoplasia.
    Martin DA; Sutton GP; Ulbright TM; Sledge GW; Stehman FB; Ehrlich CE
    Gynecol Oncol; 1989 Sep; 34(3):383-8. PubMed ID: 2548937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AgNOR of gastational trophoblastic tumors and its clinical significance].
    Yang BL
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):408-10, 442. PubMed ID: 8287726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value.
    van de Kaa CA; Schijf CP; de Wilde PC; de Leeuw H; Gemmink JH; Robben JC; Vooijs PG
    Mod Pathol; 1996 Oct; 9(10):1007-14. PubMed ID: 8902839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytophotometric DNA determination of trophoblastic neoplasia.
    Nishiya I; Moriya S; Yamashita K; Kikuchi T
    Gynecol Oncol; 1977 Jun; 5(2):103-8. PubMed ID: 195868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases].
    Li Z; Xiang Y; Dai L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):547-50. PubMed ID: 11775947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial hydatidiform moles: deoxyribonucleic acid content and course.
    Davis JR; Kerrigan DP; Way DL; Weiner SA
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):969-73. PubMed ID: 3674171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometric analysis of trophoblastic tumors].
    Fu XS
    Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):98-9. PubMed ID: 1323424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichosanthin in the treatment of hydatidiform mole. Clinical analysis of 52 cases.
    Lu PX; Jin YC
    Chin Med J (Engl); 1990 Mar; 103(3):183-5. PubMed ID: 2164464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue.
    Erdkamp FL; Schouten HC; Breed WP; Janssen WC; Hoffmann JJ; Reynders M; Schutte B; Blijham GH
    Hematol Pathol; 1994; 8(3):75-84. PubMed ID: 7982854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.